Fujiwara Y, Kano Y, Tatsumi M, Paul P
Mutat Res. 1980 Jul;71(2):243-51. doi: 10.1016/0027-5107(80)90076-7.
The effects of a tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) and/or an anti-promoter antipain (protease inhibitor) on spontaneous and ultraviolet-induced sister-chromatid exchanges (SCEs) and 6-thioguanine-resistant (6TGr) recessive mutations were examined in V79 Chinese hamster cells in culture. TPA and/or antipain neither significantly altered base-line and UV-induced immediate SCE frequencies, nor decreased the level of delayed SCEs which persisted 6-7 days after irradiation. TPA and/or antipain appeared to enhance the recovery of UV-induced 6TGr colonies at the plateau expression phase despite non-mutagenicity by themselves and unaltered metabolic cooperation. Thus, the results conceivably imply that the 6TGr-recessive mutation expression, but not fixation, can be modulated at the cell level by TPA and/or antipain. Our results, together with the recent results of Loveday and Latt, may argue against the notion that TPA enhances the antipain-suppressible SCEs as an index of mitotic recombination in relevance with a tumor-promotion mechanism.
在培养的V79中国仓鼠细胞中,研究了肿瘤启动子12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)和/或抗启动子抗蛋白酶(蛋白酶抑制剂)对自发和紫外线诱导的姐妹染色单体交换(SCE)以及6 - 硫鸟嘌呤抗性(6TGr)隐性突变的影响。TPA和/或抗蛋白酶既未显著改变基线和紫外线诱导的即时SCE频率,也未降低照射后6 - 7天持续存在的延迟SCE水平。TPA和/或抗蛋白酶似乎在平台期表达阶段增强了紫外线诱导的6TGr集落的恢复,尽管它们本身无致突变性且代谢协同作用未改变。因此,可以想象这些结果意味着TPA和/或抗蛋白酶可在细胞水平调节6TGr隐性突变的表达,但不能调节其固定。我们的结果与Loveday和Latt最近的结果一起,可能反对TPA增强抗蛋白酶可抑制的SCE作为与肿瘤促进机制相关的有丝分裂重组指标的观点。